CAAS Capital Management’s Envoy Medical Warrant COCHW Stock Holding History

CAAS Capital Management’s Portfolio COCHW Stock Details COCHW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$774	Hold	23,467	–	–	﹤0.01%	468
2024 Q4	$1.1K	Hold	23,467	–	–	﹤0.01%	354
2024 Q3	$1.88K	Hold	23,467	–	–	﹤0.01%	421
2024 Q2	$1.17K	Hold	23,467	–	–	﹤0.01%	214
2024 Q1	$2.5K	Hold	23,467	–	–	﹤0.01%	486
2023 Q4	$469	Buy	+23,467	New	+$634	﹤0.01%	476
2023 Q3	–	Sell	-23,467	Closed	-$1.17K	–	669
2023 Q2	$1.17K	Hold	23,467	–	–	﹤0.01%	656
2023 Q1	$882	Hold	23,467	–	–	﹤0.01%	688
2022 Q4	$892	Hold	23,467	–	–	﹤0.01%	733
2022 Q3	$2K	Hold	23,467	–	–	﹤0.01%	769
2022 Q2	$3K	Hold	23,467	–	–	﹤0.01%	832
2022 Q1	$6K	Hold	23,467	–	–	﹤0.01%	606
2021 Q4	$19K	Buy	+23,467	New	+$17.2K	﹤0.01%	805

Other funds holding COCHW

Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

SIM

Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

BCL

Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

CAAS Capital Management's COCHW Position: Q1 2025 in Review

CAAS Capital Management held its Envoy Medical Warrant (COCHW) position steady in Q1 2025 at 23,467 shares worth $774. The position accounts for ﹤0.01% of the portfolio, ranked #468.

CAAS Capital Management first reported a position in COCHW in Q4 2021 and has held it in 13 quarters since. The position peaked at $19K in Q4 2021. 36 funds tracked by Wall St. Rank hold COCHW as of Q1 2025.

CAAS Capital Management held 23,467 shares of Envoy Medical Warrant worth $774 as of Q1 2025.
CAAS Capital Management left its Envoy Medical Warrant share count unchanged in Q1 2025.
Envoy Medical Warrant made up ﹤0.01% of CAAS Capital Management's portfolio in Q1 2025, its #468 holding.
CAAS Capital Management first reported a position in Envoy Medical Warrant in Q4 2021 and has held it in 13 quarters since.
CAAS Capital Management's Envoy Medical Warrant position peaked at $19K in Q4 2021.
36 funds tracked by Wall St. Rank held Envoy Medical Warrant as of Q1 2025.

Based on CAAS Capital Management's 13F filing for Q1 2025, filed 1 May 2025.